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Introduction: Multiple organ failure is the commonest cause o f  death in the intensive care unit 
setting. There are numerous precipitating factors including sepsis, trauma and pancreatitis. The resulting 
tissue hypoxia, exaggerated inflammatory response and generation o f  free oxygen radicals leads to tissue 
damage and organ dysfunction. No definitive treatment exists despite considerable efforts to find a ‘magic 
bullet’. Management still revolves around support o f organ function and prevention o f  iatrogenic 
complications until recovery occurs. An increasing emphasis is being placed on prevention o f organ 
dysfunction, including maintenance o f  tissue oxygenation, nutrition and infection control. Multiple organ 
failure (MOF) is the commonest cause o f  death in the intensive care unit (ICU). A clinical assessment o f  a 
high likelihood o f  irreversible organ failure, particularly when multiple organs are involved, is the usual 
factor prompting a decision to withdraw treatment or not to add further therapy. Sepsis is one precipitating 
factor for MOF; numerous other causes o f tissue damage are well recognized, e.g. trauma, bums and 
pancreatitis. No definitive treatment exists and controversy surrounds many aspects o f  the management o f 
MOF. Problems include (i) a shortage o f  major multi-center, controlled studies in a well-defined patient 
population (other than immunotherapy trials which are often o f flaweddesign), (ii) an inclination to use 
unproved interventions,(iii) over-extrapolation o f  data from laboratory studies,(iv) an often uncritical 
acceptance o f  simplified, schematic representations o f  inflammatory mechanisms, (v) variable disease 
syndrome definitions and (vi) diagnostic imprecision. The above contribute to the current lack of 
hardened-fast rules regarding patient management; instead, there are a number o f generally accepted 
guidelines which still provide considerable scope for treatment variability. Examples o f  current grey areas 
include selective gut decontamination, extracorporeal respiratory support and prophylaxis against stress- 
ulcer-related bleeding. There is also the widespread, though as yet unproven and unlicensed, use o f  nitric 
oxide inhalation in acute lung injury, and the quest for a single ‘magic bullet’ to ameliorate the 
generalized, exaggerated inflammatory response associated with severe sepsis. In the case o f  the strongly 
promoted concept o f  ‘supranormalizing’ hemodynamic parameters in the critically ill patient, whereby 
elevated values o f  cardiac output, oxygen delivery and oxygen consumption were striven for, it was 
several years before this approach was shown to be ineffective. Nevertheless, and despite the above 
caveats, there has been progress in several areas. A better, though still incomplete, insight is being gained 
into the pathophysiological mechanisms underlying the exaggerated inflammatory response that 
frequently underlies MOF. There is a greater appreciation o f  the need to prevent organ dysfunction by 
optimizing the circulation and avoidance or rapid correction o f  tissue hypoxia in high-risk patients. There 
is are cognition o f  the importance o f  standard definitions, for example sepsis, the systemic inflammatory 
response syndrome (SIRS), the multiple organ dysfunction syndrome (MODS) , the acute respiratory 
distress syndrome (ARDS) and acute lung injury. There is also a recognized need to improve the 
description o f organ dysfunction. In addition, general advances and the increasing availability o f intensive 
care, superior ‘whole body’ organsupport, appropriate infection control, nutrition and pressure area care, 
and avoidance o f  iatrogenic pulmonary barotrauma, have all contributed to improvements in outcome.
Objective: To determine whether translocation o f  bacteria or endotoxin occurred into the 
thoracic duct in patients with multiple organ failure (MOF) is take active role in MOF.
Methods: 1. Meta-analysis o f  156 patients from retrospective -  preview date base o f  patients 
in MOF. 2. The thoracic duct was drained for 5 days in patients with MOF caused either by 
generalized fecal peritonitis (n =  4) or by an event without clinical and microbiologic evidence o f 
infection (n = 4). Patients without MOF who were undergoing a transthoracic esophageal resection 
served as controls. In lymph and blood, concentrations o f  endotoxin, proinflammatory cytokines, 
and anti-inflammatory cytokines were measured.
Experimental data: Description -  in heart o f  M ousses, was examined the function o f  heart 
(in vitro), in 3 state: 1. Normal without intervention. (Control group). 2. With lymph o f  MOF state. 
3. With MOF state + thoracic duct ligation.
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Conclusion: This meta-analysis study provides evidence that translocation (especially o f  
endotoxin) occurs into the thoracic duct. These data do support the concept that the thoracic duct is 
a major route o f  bacterial translocation in patients with MOF
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Introduction: The laparotomie suppurated eventrated wound is a postoperative complication 
caused by contamination, suppuration and necrosis o f  the abdominal wall anatomical layers 
(subcutaneous fat, ventral aponeurosis, peritoneum) with eventration o f  abdominal organs. The use 
o f  negative pressure therapy in the treatment o f  laparotomie suppurated eventrated wound is 
described worldwide in the specialty literature, but its efficiency depending on the etiology o f  the 
intraabdominal infection remains insufficiently studied.
Purpose and Objectives: Reporting the results o f  the treatement with negative pressure o f  
the patients with laparotomie suppurated eventrated wounds.
Materials and Methods: From October 2012 until March 2014, negative pressure therapy was 
used in the treatement o f  laparotomie suppurated eventrated wounds in 22 patients with the mean age o f  
64.2 and sex ratio M:F being 15:7. The study included patients with laparotomie suppurated eventrated 
wounds due to diffuse peritonitis in the following nosologies: inguinal hernia with small bowel necrosis 
(1), postoperative ventral hernia (1), gastric adenocarcinoma with perforation (1), gangrenous 
cholecystic perforation (1), closed abdominal trauma with bowel (1) and small intestine injury (1), 
fistular Crohn's disease (1), gangrenous perforative appendicitis (3), colon ischemia and necrosis with 
perforation (2), nonspecific ulcerative colitis with intestinal obstruction (1), colon diverticulum 
perforation (2), benign tumor o f the colon with mechanic obstruction (1), colon adenocarcinoma with 
mechanic obstruction (3), colon adenocarcinoma with perforation (3).
Results: The negative pressure therapy set at 75-105 mmHg was applied after necrectomy, 
with a mean duration o f  the sessions o f  48-72 hours. The number o f  sessions was determined by the 
type o f  intraabdominal infection. Wound closure criteria were: the presence o f  mature granulation 
tissue, the type o f  inflammatory-regeneratory cytological imprints and the decrease o f  the amounts 
o f  wound microflora from 106-7 to 102“’. The treatment was carried out in two stages: the first stage 
- negative pressure therapy with suturing o f  the ventral aponeurosis, the second stage - continuing 
negative pressure therapy with complete closure o f  the laparotomie wound. Definitive closure o f  the 
abdominal wall was possible in 19 patients. 3 patients died, the mortality rate constituting 13.6%.
Conclusions: The use o f  negative pressure therapy in the treatment o f  the laparotomie 
suppurated eventrated wounds allows to: eliminate the septic source, decrease the frequency o f 
dressings changes- one at 48-72 hours with a fascial closure rate o f  86.4%.
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Introduction: Variceal bleeding is a severe complication o f  cirrhosis leading to significant 
morbidity and mortality. Ruptured esophageal varices cause approximately 70% o f  all upper
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